Use cautionMedical device recall · FDA · Published April 15, 2025
Philips Tempus Pro Patient Monitor Software Update Recalls: Freezing and Inaccurate ECG
Philips recalls Tempus Pro Patient Monitors with software versions prior to vx.40 due to freezing issues and inaccurate 12-lead ECG readings. Affected models include 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007.
Patient Monitor software update to address issues:1)May freeze at startup with MPM Application error and Attention Restart Required messages,2)Monitor may freeze and reboot at start of 12-lead ECG or after, 3)May reboot after intermittent connection with Smart Mount, 4) 12-lead ECG measurements with Louvain algorithm and software before vx.36 could produce inaccurate rhythm/morphology statements.
Take action
Contact the company
📍Recalling firmRemote Diagnostic Technologies Ltd.Farnborough Aerospace Centre, Aerospace Boulevard · Farnborough, United Kingdom
✎ GovInfoNow plain-language explainer
Philips is recalling Tempus Pro Patient Monitors with software versions before vx.40 because they can freeze during startup, ECG tests, or smart mount connections, and may give inaccurate heart rhythm readings. This could lead to incorrect medical decisions if the monitor is used for patient monitoring. Read more at govinfonow.com/recall/52451-philips-tempus-pro-patient-monitor-software-update-recalls-freezing-and.
“Philips Tempus Pro Patient Monitor Software Update Recalls: Freezing and Inaccurate ECG.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/52451-philips-tempus-pro-patient-monitor-software-update-recalls-freezing-and. Based on FDA recall #Z-1729-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1729-2025%22&limit=1).
The FDA announced on April 15, 2025, that Remote Diagnostic Technologies Ltd. is recalling Philips Tempus Pro Patient Monitors due to software issues that may cause the device to freeze or produce inaccurate ECG data. Owners should contact the company for a software update.
The monitor's software may freeze at startup or during ECG measurements, potentially causing inaccurate rhythm statements. The FDA cited these issues as the basis for the Class II recall.
Context
GovInfoNow's records show Remote Diagnostic Technologies Ltd. has 11 other recalls on record since November 17, 2020. Other recent recalls of similar products include a Tempus Pro Patient Monitor software error dated April 16, 2025, and an Inseego USB8 4G Dongle Kit recall dated May 30, 2025. Philips Cardiac Workstation 5000 and 7000 recalls regarding inaccurate heart rate data were reported on July 1, 2026.
How to tell if you have this one
Check the product's software version (prior to vx.40) or the model reference numbers listed: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007.
Brand
Philips
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Review the monitor's software version to confirm it is prior to vx.40.
Update Software
Update to software version vx.40 or later to fix the freezing and accuracy issues.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 42 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution including in the states of AZ, VA, FL, CA, TX, NM, IA, NJ, TN, OH, KS, IN, NC, IL, WY, WI, NV, NY, NE, PA, AL, , MA, GA, MO, CO, OK, KY, OR, MS, MI, HI, WA, UT, WV, ID, ND, NH, MN, MT, ME, MD, DE, DC…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, California, Colorado, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 29 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1729-2025 (April 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1729-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.